Overview Study to Treat Uveitis Associated Macular Edema Status: Terminated Trial end date: 2006-12-01 Target enrollment: Participant gender: Summary The purpose of this study is to determine whether denufosol tetrasodium (INS37217) Intravitreal Injection is well tolerated and has the potential to treat uveitis associated macular edema. Phase: Phase 2 Details Lead Sponsor: Merck Sharp & Dohme Corp.